Imatinib Completed Phase N/A Trials for Leukemias Treatment

IndicationsStatusPurposePhase
CompletedTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT00386373Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia Patients